Glucagon-like peptide-1 receptor agonists (GLP-1s) are increasingly prescribed for the treatment of diabetes and obesity, with growing interest in their potential impact on mental health outcomes. As more clients present with histories of GLP-1 use, mental health professionals must understand both the physiological and psychological implications of these medications. This training provides an overview of GLP-1 medicines, including their mechanisms of action, common indications, and side effects, while examining emerging research on their relationships to mood, anxiety, eating behavior, cognition, and quality of life. The course will also explore clinical considerations, including weight stigma, identity changes, medication access, and interdisciplinary collaboration. Emphasis will be placed on helping clinicians integrate medication awareness into holistic, ethical, and person-centered mental health care.

Upon completion of the webinar, participants will be able to:

• Describe the basic mechanisms of action, indications, and common side effects of GLP-1 medications and their relevance to mental health practice.
• Identify emerging research findings related to GLP-1 use and mental health outcomes, including mood, anxiety, eating behaviors, and psychosocial functioning.
• Apply clinical considerations for working with clients using GLP-1 medications, including assessment, psychoeducation, stigma-informed care, and collaboration with medical providers.